Daymark Wealth Partners, LLC Tg Therapeutics, Inc. Transaction History
Daymark Wealth Partners, LLC
- $2.43 Billion
- Q1 2024
A detailed history of Daymark Wealth Partners, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Daymark Wealth Partners, LLC holds 23,500 shares of TGTX stock, worth $418,065. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,500
Previous 13,500
74.07%
Holding current value
$418,065
Previous $230,000
55.22%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
269Shares Held
87.7MCall Options Held
2.72MPut Options Held
1.74M-
Vanguard Group Inc Valley Forge, PA13.5MShares$241 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$193 Million0.0% of portfolio
-
State Street Corp Boston, MA7.8MShares$139 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.48MShares$62 Million0.02% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.33MShares$59.2 Million0.06% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $2.58B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...